2016
DOI: 10.2106/jbjs.o.00209
|View full text |Cite
|
Sign up to set email alerts
|

OP-1 Compared with Iliac Crest Autograft in Instrumented Posterolateral Fusion

Abstract: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
19
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(19 citation statements)
references
References 31 publications
(48 reference statements)
0
19
0
Order By: Relevance
“…This agrees with the current finding that the co-delivery of these factors creates a potent stimulus for new bone formation. The current clinical practice of delivering single supra-physiological doses of BMP-2 could be the reason for its unpredictable induction of new bone formation (Delawi et al, 2016;Hustedt et al, 2014;Vaccaro et al, 2008). Therefore, it is of great interest to elucidate if this co-delivery approach may indeed result in a reduction of the minimal effective BMP dose, considering the high costs (Garrison et al, 2010) and side effects (Carragee et al, 2011b;Epstein, 2013) associated with its current use.…”
Section: Croes Et Almentioning
confidence: 99%
See 1 more Smart Citation
“…This agrees with the current finding that the co-delivery of these factors creates a potent stimulus for new bone formation. The current clinical practice of delivering single supra-physiological doses of BMP-2 could be the reason for its unpredictable induction of new bone formation (Delawi et al, 2016;Hustedt et al, 2014;Vaccaro et al, 2008). Therefore, it is of great interest to elucidate if this co-delivery approach may indeed result in a reduction of the minimal effective BMP dose, considering the high costs (Garrison et al, 2010) and side effects (Carragee et al, 2011b;Epstein, 2013) associated with its current use.…”
Section: Croes Et Almentioning
confidence: 99%
“…Currently, the bone morphogenetic proteins (BMPs) are the only osteoinductive alternatives for bone grafting in the treatment of large bone defects (Carreira et al, 2014;Ronga et al, 2013). However, their current dosage and delivery method is associated with serious adverse effects (Carragee et al, 2011b;Epstein, 2013), high costs (Garrison et al, 2010) and unpredictable outcomes (Delawi et al, 2016;Hustedt et al, 2014;Vaccaro et al, 2008).…”
Section: Introductionmentioning
confidence: 99%
“…Delawi et al 163 in a prospective randomized study (level 1) evaluated OP-1 for single level instrumented posterolateral fusion surgery for degenerative or isthmic spondylolisthesis. 119 patients undergoing doi: 10.14444/3033…”
Section: Osteogenic Protein 1 (Op-1) In Lumbar Spinementioning
confidence: 99%
“…The situation is exacerbated by a rising number of devastating traumatic war injuries for which often no other treatment option than amputation exists due to the extensive loss of bone and soft tissue6. Current treatment options are associated with high morbidity789 or deficient efficacy10. Mesenchymal stem cells (MSCs) in combination with various scaffolds are under intensive investigation and show promising achievements11121314.…”
mentioning
confidence: 99%